Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Transient global amnesia
ADR ID BADD_A04372
ADR Hierarchy
17      Nervous system disorders
17.03      Mental impairment disorders
17.03.02      Memory loss (excl dementia)
17.03.02.004      Transient global amnesia
19      Psychiatric disorders
19.20      Dementia and amnestic conditions
19.20.01      Amnestic symptoms
19.20.01.004      Transient global amnesia
Description A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30) [MeSH]
MedDRA Code 10044380
MeSH ID D020236
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Transient global amnesia | Amnesia, Transient Global | Global Amnesia, Transient | TGA (Transient Global Amnesia) | TGAs (Transient Global Amnesia) | Transient Global Amnesia
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000404%
BADD_D00115Amiodarone0.000595%
BADD_D00142Anastrozole0.000754%
BADD_D00209Baclofen0.000337%
BADD_D00659Dicyclomine--
BADD_D01253Lenalidomide0.001158%
BADD_D01322Losartan0.000013%
BADD_D02018Sildenafil0.000831%
BADD_D02026Simvastatin0.000031%
BADD_D02106Tadalafil0.001439%
BADD_D02335Vardenafil--
BADD_D02346Venlafaxine0.000149%
BADD_D02436Atorvastatin0.000266%
BADD_D02464Fingolimod0.001158%
The 1th Page    1    Total 1 Pages